CVS Health Co. (NYSE:CVS) Shares Sold by Acropolis Investment Management LLC

Acropolis Investment Management LLC decreased its holdings in CVS Health Co. (NYSE:CVS) by 21.6% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,616 shares of the pharmacy operator’s stock after selling 444 shares during the quarter. Acropolis Investment Management LLC’s holdings in CVS Health were worth $102,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. MidAtlantic Capital Management Inc. acquired a new position in CVS Health in the 3rd quarter worth about $25,000. Livelsberger Financial Advisory acquired a new position in CVS Health in the 3rd quarter worth about $31,000. Reston Wealth Management LLC acquired a new position in shares of CVS Health during the third quarter valued at approximately $32,000. First Community Trust NA raised its holdings in shares of CVS Health by 116.2% during the second quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock valued at $33,000 after acquiring an additional 302 shares during the last quarter. Finally, Kathleen S. Wright Associates Inc. acquired a new position in shares of CVS Health during the third quarter valued at approximately $33,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Stock Down 0.2 %

Shares of NYSE CVS opened at $59.85 on Friday. CVS Health Co. has a 12-month low of $52.71 and a 12-month high of $83.25. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. The stock has a market cap of $75.32 billion, a P/E ratio of 15.19, a PEG ratio of 1.02 and a beta of 0.55. The business’s fifty day simple moving average is $59.36 and its 200-day simple moving average is $58.75.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating analysts’ consensus estimates of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The company had revenue of $95.43 billion for the quarter, compared to analysts’ expectations of $92.72 billion. During the same period last year, the firm earned $2.21 earnings per share. CVS Health’s quarterly revenue was up 6.3% on a year-over-year basis. As a group, equities analysts predict that CVS Health Co. will post 5.37 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, November 1st. Shareholders of record on Monday, October 21st were paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 4.44%. The ex-dividend date was Monday, October 21st. CVS Health’s dividend payout ratio is presently 67.51%.

Analyst Upgrades and Downgrades

A number of brokerages have commented on CVS. Mizuho reduced their target price on CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a report on Thursday, October 24th. Deutsche Bank Aktiengesellschaft lowered their price objective on CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a research report on Friday, August 9th. Wells Fargo & Company upgraded CVS Health from an “equal weight” rating to an “overweight” rating and increased their price objective for the stock from $60.00 to $66.00 in a research report on Monday, November 18th. StockNews.com lowered CVS Health from a “hold” rating to a “sell” rating in a research report on Thursday, November 14th. Finally, Evercore ISI increased their price objective on CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 8th. One analyst has rated the stock with a sell rating, seven have issued a hold rating and thirteen have assigned a buy rating to the stock. Based on data from MarketBeat, CVS Health currently has an average rating of “Moderate Buy” and a consensus price target of $70.33.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.